Ignite Creation Date:
2024-05-06 @ 6:42 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05754853
Status:
RECRUITING
Last Update Posted:
2023-04-13
First Post:
2023-02-22
Brief Title:
A Study of MRG002 Versus Investigators Choice of Chemotherapy in the Treatment of Patients With HER2-positive Unresectable Advanced or Metastatic Urothelial Cancer
Sponsor:
Shanghai Miracogen Inc
Organization:
Shanghai Miracogen Inc